Breaking News

Mission Pharmacal Acquires ProSolus Pharmaceuticals

Acquisition adds expertise in transdermal drug development and manufacturing

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mission Pharmacal Company recently acquired the assets of ProSolus Pharmaceuticals headquartered in Miami, FL. Now a wholly owned subsidiary of Mission, ProSolus Inc., offers expertise in the development and manufacturing of sophisticated and convenient transdermal—through the skin—drug delivery products to treat a variety of health conditions. “ProSolus is the new jewel in Mission’s crown as a manufacturing supplier,” said Pete Valko, chief operating officer, ProSolus Inc., who is adding thi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters